Found 9 matching trials
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke
PHASE4LUMEN is a multicenter, randomized, double-blind, placebo-controlled superi...
Location
Multiple Locations
The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy
PHASE2This study aims to evaluate whether oral DLBS1033 can improve clinical symp...
Location
Dr. Moewardi Regional General Hospital
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
PHASE4This randomized, double-blind, placebo-controlled trial aims to evaluate th...
Location
Dr. Moewardi Regional General Hospital
The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
PHASE2DLBS1033 is bioactive protein fraction which extracted from Lumbricus rubel...
Location
Indonesia University
Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo
PHASE4The goal of this clinical trial is to learn if oral lumbrokinase DLBS1033 w...
Location
Dr. Moewardi Regional General Hospital
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
PHASE2Stroke is one of the most common non-communicable diseases worldwide. It is...
Location
Bethesda Hospital Yogyakarta
THE EFFECT OF LUMBRICUS RUBELLUS DLBS1033 EXTRACT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
PHASE4This randomized, open-label, controlled trial aims to evaluate the effect o...
Location
Dr. Moewardi Regional General Hospital
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
PHASE3This is a 3-arm, prospective, randomized, double-blind, and controlled clin...
Location
Stroke Unit, Department of Neurology, Faculty of Medicine, Gadjah Mada University, dr. Sardjito Hospital
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PHASE1This will be a pilot multi-arm clinical trial investigating the feasibility...
Location
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)